BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17659)

  • 1. Childhood pheochromocytoma: treatment with alpha methyl tyrosine for resistant hypertension.
    Robinson RG; DeQuattro V; Grushkin CM; Lieberman E
    J Pediatr; 1977 Jul; 91(1):143-7. PubMed ID: 17659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pheochromocytoma resistant to alpha-adrenergic blockade.
    Hauptman JB; Modlinger RS; Ertel NH
    Arch Intern Med; 1983 Dec; 143(12):2321-3. PubMed ID: 6139989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical management of pheochromocytoma with the use of metyrosine.
    Perry RR; Keiser HR; Norton JA; Wall RT; Robertson CN; Travis W; Pass HI; Walther MM; Linehan WM
    Ann Surg; 1990 Nov; 212(5):621-8. PubMed ID: 1978640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Metastatic malignant pheochromocytoma: treatment with alpha-methyl-para-tyrosine].
    Tcherdakoff P; Ménard J; Bedrossian J; Vaysse J; Alexandre JM; Milliez P
    Sem Hop; 1972 May; 48(25):1779-87. PubMed ID: 4405188
    [No Abstract]   [Full Text] [Related]  

  • 5. Metyrosine and pheochromocytoma.
    Steinsapir J; Carr AA; Prisant LM; Bransome ED
    Arch Intern Med; 1997 Apr; 157(8):901-6. PubMed ID: 9129550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversibility of catecholamine-induced dilated cardiomyopathy in a child with a pheochromocytoma.
    Imperato-McGinley J; Gautier T; Ehlers K; Zullo MA; Goldstein DS; Vaughan ED
    N Engl J Med; 1987 Mar; 316(13):793-7. PubMed ID: 2881206
    [No Abstract]   [Full Text] [Related]  

  • 7. [A long survived case of malignant pheochromocytoma treated with alpha-methyl-p-tyrosine and midaglizol (DG-5128)].
    Okada S; Ohshima K; Onai T; Umahara M; Kobayashi S; Ishihara H
    Nihon Gan Chiryo Gakkai Shi; 1990 Jun; 25(6):1221-5. PubMed ID: 1975832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative catecholamine pathways after tyrosine hydroxylase inhibition in malignant pheochromocytoma.
    Kuchel O; Buu NT; Edwards DJ
    J Lab Clin Med; 1990 Apr; 115(4):449-53. PubMed ID: 1969915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Alpha-methyl-paratyrosine in the treatment of malignant pheochromocytoma].
    Decoulx M; Wemeau JL; Racadot-Leroy N; Grimbert I; Proye C; Plane C
    Rev Med Interne; 1987; 8(4):383-8. PubMed ID: 3423477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of malignant pheochromocytoma treated with 131I-metaiodobenzylguanidine and alpha-methyl-p-tyrosine.
    Nakagami Y; Nomura K; Kusakabe K; Miko N; Tsushima T; Demura H
    Jpn J Med; 1990; 29(3):329-33. PubMed ID: 1980321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. alpha-Methyl-p-tyrosine: a review of its pharmacology and clinical use.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1981 Feb; 21(2):81-9. PubMed ID: 7009139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological conference: a 42-year-old woman with respiratory distress, abdominal pain, and hypertension.
    Kulstad C; D'Amore J
    Acad Emerg Med; 2005 May; 12(5):453-60. PubMed ID: 15860698
    [No Abstract]   [Full Text] [Related]  

  • 13. An atrial pheochromocytoma-induced hypertensive crisis resistant to nitroprusside.
    Anton AH; Sherman BW; Lina AA; Acheson LS
    Int J Clin Pharmacol Ther Toxicol; 1993 Feb; 31(2):89-92. PubMed ID: 8096204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant pheochromocytoma. Effect of oral alpha-methyl-p-tyrosine upon catecholamine metabolism.
    Hengstmann JH; Gugler R; Dengler HJ
    Klin Wochenschr; 1979 Apr; 57(7):351-5. PubMed ID: 108462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phaeochromocytoma with myocarditis managed with alpha-methyl-p-tyrosine.
    Begnall WE; Salway JG; Jackson EW
    Postgrad Med J; 1976 Oct; 52(612):653-6. PubMed ID: 995792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of alpha-methyltyrosine to prevent hypertensive crisis in pheochromocytoma.
    Ram CV; Meese R; Hill SC
    Arch Intern Med; 1985 Nov; 145(11):2114-5. PubMed ID: 2865938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pheochromocytoma: urinary catecholamine excretion and insulin secretion after -methyl-p-tyrosine treatment.
    Parra A; Porcayo F; Santos D
    Helv Paediatr Acta; 1972 Jul; 27(3):309-14. PubMed ID: 4645656
    [No Abstract]   [Full Text] [Related]  

  • 18. Phaeochromocytoma and diabetes mellitus: further evidence that alpha 2 receptors inhibit insulin release in man.
    Isles CG; Johnson JK
    Clin Endocrinol (Oxf); 1983 Jan; 18(1):37-41. PubMed ID: 6303636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of extra-adrenal pheochromocytoma treated with alpha-methyl-p-tyrosine].
    Torres Zamora M; Girón N; Ortiz Quezada F; Serrano P
    Arch Inst Cardiol Mex; 1972; 42(1):113-21. PubMed ID: 4401165
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of alpha-methyl-paratyrosine on the urinary excretion of catecholamines in patients with pheochromocytoma].
    Rivero Sánchez M; Selgas Gutiérrez R; Lorenzo Aguiar MD; Martínez Muñoz I; Beberide García JM; Almaraz Jiménez M; Rińon Aguilar C; Sánchez Sicilia L
    Rev Clin Esp; 1981 May; 161(4):235-9. PubMed ID: 7280330
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.